AI assistant
TRISTEL PLC — Director's Dealing 2026
Mar 23, 2026
7990_dirs_2026-03-23_ad2d3e22-2086-44cd-ac66-8164703387c2.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 6737X
Tristel PLC
23 March 2026

Tristel plc
("Tristel" or the "Company")
Director/PDMR Shareholding
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that it was notified on 20 March 2026 that Caroline Stephens, Non-Executive Director of the Company, purchased 2,597 ordinary shares of 1 penny each in the Company ("Ordinary Shares") at a price of 382.47 pence per Ordinary Share.
Following the purchase, Caroline Stephens' beneficial interest in the Company, including those held by her PCA, is 6,878 Ordinary Shares, representing approximately 0.014 per cent. of the Company's issued share capital.
For further information please contact:
| Tristel plc | Via Walbrook PR | |||
| Matt Sassone, Chief Executive Officer | www.investors.tristel.com | |||
| Anna Wasyl, Chief Financial Officer | ||||
| Walbrook PR Ltd | Tel: 020 7933 8780 or [email protected] | |||
| Paul McManus / Lianne Applegarth / Anna Dunphy | Mob: 07980 541 893/ 07584 391 303/ 07876 741 001 | |||
| Cavendish Capital Markets Ltd | Tel: 020 7220 0500 | |||
| Geoff Nash / Callum Davidson / Joe Smith (Corporate Finance) | ||||
| Sunila de Silva (Corporate Broking) / Louise Talbot (Sales) | ||||

About Tristel plc
Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals with products under the Tristel brand, which also encompasses its sporicidal surface disinfection range offered as a sustainable alternative to commonly used pre‑wetted plastic wipe.
Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 270 people across 16 subsidiaries selling into 40+ countries. The Company targets delivering double-digit revenue growth annually, an adjusted EBITDA margin of at least 25% and a continuing progressive year-on-year growth in dividends, underpinned by robust cash generation.
The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).
For more information about Tristel's product range please visit: https://tristel.com
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Caroline Stephens
2
Reason for the notification
a)
Position/status
Non-Executive Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Tristel plc
b)
LEI
2138009DZ4LH9CZGF662
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares of 1p each in Tristel plc
GB00B07RVT99
b)
Nature of the transaction
Purchase of Ordinary Shares
c)
Price(s) and volume(s)
| Price | Volume |
| 382.47 | 2,597 |
d)
Aggregated information
- Aggregated volume
- Price
2,597 Ordinary Shares of 1 penny each
382.47 pence
e)
Date of the transaction
20 March 2026
f)
Place of the transaction
London Stock Exchange (AIM)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHDZGZFVFLGVZG